<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372724">
  <stage>Registered</stage>
  <submitdate>11/04/2017</submitdate>
  <approvaldate>26/04/2017</approvaldate>
  <actrnumber>ACTRN12617000588392</actrnumber>
  <trial_identification>
    <studytitle>Evaluating pre-operative carbohydrate supplementation in hip fracture patients - A feasibility study for a randomised control trial </studytitle>
    <scientifictitle>Is a randomised control trial to evaluate the impact of pre-operative carbohydrate supplementation on patient outcomes feasible in acute hip fracture patients admitted to The Prince Charles Hospital Hip Fracture Unit?</scientifictitle>
    <utrn />
    <trialacronym>CHOinNOF</trialacronym>
    <secondaryid>Nil known </secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hip Fracture</healthcondition>
    <healthcondition>Malnutrition</healthcondition>
    <healthcondition>Insulin Resistance</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Fractures</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Evaluating the provision of pre-operative carbohydrate drinks in the acute hip fracture setting: A feasibility study for a randomised control trial
Intervention: Carbohydrate supplement (0.5kcal/ml, clear fluid liquid; 50.4g carbohydrate (maltodextrin) per 400mL serve.)
400mL carbohydrate supplement to be consumed orally within 1hour, 2-3 hours before surgery. Single dosage only and consumption recorded by the administrating staff member.</interventions>
    <comparator>Control arm will consist of standard peri-operative care - patients fasting from mid night.

pre, intra and post operative standardised care pathways align with the Australian and New Zealand Guideline for Hip Fracture Care - Improving Outcomes in Hip Fracture management of Adults guideline </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Recruitment rate of participants </outcome>
      <timepoint>when sample size is reached </timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Integration success of the intervention into routine clinical practice (success of feasbility study for standard care use; composite outcome) 
Review of medication charts to determine correctly prescribed and administered supplements (measured by script)
Review of OT schedule and changes to OT schedule as a result of supplement consumption (measured by mins delayed)</outcome>
      <timepoint>when sample size is reached</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Adherence with prescribed carbohydrate supplement. 
Documented by administering staff member </outcome>
      <timepoint>DAY 1 post surgery </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient perceived quality of life using the EQ-5D tool 
</outcome>
      <timepoint>DAY 2 post operative and at 10 week fracture clinic </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Unfavorable outcomes - incidence of aspiration (documented in medical notes) </outcome>
      <timepoint>from DAY 0- DAY 5 </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hospital Length of Stay - review of medical notes</outcome>
      <timepoint>10 week follow up </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient functional status (DEMMI score)</outcome>
      <timepoint>Day 1/2 + 10 week follow up </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Supplement intolerance and subsequent nausea/vomiting- review of consumption + antiemetic use + episodes of vomiting collected from medical chart/medication list </outcome>
      <timepoint>Day 0- Day 5 </timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- fractured neck of femur
- community dwelling prior to admission </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- non operative managment 
- diabetes requiring insulin
- oral feeding aversion or carbohydrate intolerance
- admission for supported accomodation including nursing home and residential aged care facilities 
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes </concealment>
    <sequence>Block randomisation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>32 participants will be required to determine feasibility 
descriptive statistics will be presented for all variables. Univariable associations between control and intervention groups analysed by Chi square as well as thematic analysis for non-consent, consumption or delivery concerns</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>22/05/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>32</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>The Prince Charles Hospital - Chermside</hospital>
    <postcode>4032 - Chermside</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Prince Charles Hospital, Hip Fracture Unit </primarysponsorname>
    <primarysponsoraddress>The Prince Charles Hospital 
Rode Road, Chermside  QLD 4053</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>The Prince Charles Hospital Foundation - Emerging Researcher Grant </fundingname>
      <fundingaddress>The Prince Charles Hospital 
Rode Road, Chermside  QLD 4053</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This feasibility trial will evaluate the provision of pre-operative carbohydrate drinks in the acute hip fracture setting to inform feasible and clinically relevant reserach protocol to enable a larger efficacy study to answer the research question. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Prince Charles Hopsital </ethicname>
      <ethicaddress>The Prince Charles Hospital 
Rode Road, Chermside  QLD 4053</ethicaddress>
      <ethicapprovaldate>4/04/2017</ethicapprovaldate>
      <hrec>HREC/17QPCH/90</hrec>
      <ethicsubmitdate>9/03/2017</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Sally Fraser</name>
      <address>The Prince Charles Hospital
Hip Fracture Unit, Level 2
Rode Road, Chermside QLD 4032</address>
      <phone>61 7 3139 5583</phone>
      <fax />
      <email>sally.fraser3@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Sally Fraser</name>
      <address>The Prince Charles Hospital 
Nutrition and Dietetics Department, Building 14
Rode Road, Chermside QLD 4035</address>
      <phone>61731395583</phone>
      <fax />
      <email>sally.fraser3@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Sally Fraser</name>
      <address>The Prince Charles Hospital 
Nutrition and Dietetics Department, Building 14
Rode Road, Chermside QLD 4035</address>
      <phone>61731395583</phone>
      <fax />
      <email>sally.fraser3@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>